Suppr超能文献

MCM2免疫细胞化学染色在宫颈病变中的诊断价值及其与HPV感染的关系

Diagnostic value of MCM2 immunocytochemical staining in cervical lesions and its relationship with HPV infection.

作者信息

Zheng Jian

机构信息

Department of Gynecology and Obstetrics, Affiliated Hospital of Inner Mongolia Medical University 1 Channel North Road, Huimin District, Hohhot City, Inner Mongolia Autonomous Region, P. R. China.

出版信息

Int J Clin Exp Pathol. 2015 Jan 1;8(1):875-80. eCollection 2015.

Abstract

Cervical cancer remains the fourth most common cause of cancer-related deaths in women worldwide, and human papillomavirus infection represents the most important risk factor for the development of cervical cancer. Minichromosome maintenance protein-2 has been previously identified by DNA microarray and transcriptional profiling as genes that is overexpressed in cervical carcinomas. 183 cases were enrolled and tested with thin prep liquid-based cytology test. The expressions of human papillomavirus were detected and minichromosome maintenance protein-2 immuncytochemical test was performed on liquid-based pap smears from the samples. Those results were compared with the cervical histopathology results. The positive expression rates of minichromosome maintenance protein-2 and high-risk type human papillomavirus increased with the severity of cervical lesions. The expression level of MCM2 was positively correlated with high-risk types of human papillomavirus. In cervical carcinoma and precancerous lesions, minichromosome maintenance protein-2 was overexpressed and positively correlated with the high risk types of human papillomavirus. As minichromosome maintenance protein-2 immuncytochemical detection was better than genotyping of human papillomavirus, minichromosome maintenance protein-2 may serve as a useful marker in the screening of cervical carcinoma and precancerous lesions and improve the diagnosis of atypical squamous cell of undetermined significance. The joint application can improve the sensitivity and specificity of diagnosis.

摘要

宫颈癌仍是全球女性癌症相关死亡的第四大常见原因,人乳头瘤病毒感染是宫颈癌发生的最重要风险因素。微小染色体维持蛋白2先前已通过DNA微阵列和转录谱分析被鉴定为在宫颈癌中过度表达的基因。纳入183例患者并进行薄层液基细胞学检测。检测人乳头瘤病毒的表达,并对样本的液基巴氏涂片进行微小染色体维持蛋白2免疫细胞化学检测。将这些结果与宫颈组织病理学结果进行比较。微小染色体维持蛋白2和高危型人乳头瘤病毒的阳性表达率随宫颈病变严重程度增加而升高。MCM2的表达水平与高危型人乳头瘤病毒呈正相关。在宫颈癌和癌前病变中,微小染色体维持蛋白2过度表达且与高危型人乳头瘤病毒呈正相关。由于微小染色体维持蛋白2免疫细胞化学检测优于人乳头瘤病毒基因分型,微小染色体维持蛋白2可作为宫颈癌和癌前病变筛查的有用标志物,并改善意义不明确的非典型鳞状细胞的诊断。联合应用可提高诊断的敏感性和特异性。

相似文献

2
[Diagnostic value of p16/mcm2 dual staining in cervical intraepithelial neoplasia and its association with high-risk HPV infection].
Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Sep 10;38(9):1241-1245. doi: 10.3760/cma.j.issn.0254-6450.2017.09.020.
3
Minichromosome Maintenance Complex (MCM) Genes Profiling and MCM2 Protein Expression in Cervical Cancer Development.
Asian Pac J Cancer Prev. 2019 Oct 1;20(10):3043-3049. doi: 10.31557/APJCP.2019.20.10.3043.
4
Detection of high-grade neoplasia in air-dried cervical PAP smears by a microRNA-based classifier.
Oncol Rep. 2018 Mar;39(3):1099-1111. doi: 10.3892/or.2018.6214. Epub 2018 Jan 12.
6
Can the careHPV test performed in mobile units replace cytology for screening in rural and remote areas?
Cancer Cytopathol. 2016 Aug;124(8):581-8. doi: 10.1002/cncy.21718. Epub 2016 Apr 12.
8
Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
Diagn Cytopathol. 2017 May;45(5):384-390. doi: 10.1002/dc.23678. Epub 2017 Mar 1.
9
Do Infection Patterns of Human Papillomavirus Affect the Cytologic Detection of High-Grade Cervical Lesions on Papanicolaou Tests?
Arch Pathol Lab Med. 2018 Mar;142(3):347-352. doi: 10.5858/arpa.2016-0478-OA. Epub 2017 Nov 21.
10
Application of human papillomavirus in screening for cervical cancer and precancerous lesions.
Asian Pac J Cancer Prev. 2013;14(5):2979-82. doi: 10.7314/apjcp.2013.14.5.2979.

引用本文的文献

1
Alcohol consumption and DNA methylation: an epigenome-wide association study within the French E3N cohort.
Clin Epigenetics. 2025 Jul 7;17(1):118. doi: 10.1186/s13148-025-01893-1.
2
Thymopoietin-, -, and - Isoforms Increased Expression in Cervical Cancer Cells.
Can J Infect Dis Med Microbiol. 2025 Apr 9;2025:1668482. doi: 10.1155/cjid/1668482. eCollection 2025.
3
RAP1-GTPase immunostaining is altered in human precancerous and cancerous cervical lesions.
Biomark Med. 2024;18(17-18):771-785. doi: 10.1080/17520363.2024.2394384. Epub 2024 Sep 10.
4
Identification of the HNSC88 Molecular Signature for Predicting Subtypes of Head and Neck Cancer.
Int J Mol Sci. 2023 Aug 22;24(17):13068. doi: 10.3390/ijms241713068.
7
MicroRNA-186-3p attenuates tumorigenesis of cervical cancer by targeting MCM2.
Oncol Lett. 2021 Jul;22(1):539. doi: 10.3892/ol.2021.12800. Epub 2021 May 19.
9
A Novel Four-Gene Prognostic Signature as a Risk Biomarker in Cervical Cancer.
Int J Genomics. 2020 Dec 14;2020:4535820. doi: 10.1155/2020/4535820. eCollection 2020.
10
and Are Potential Biomarkers for the Diagnosis and Prognosis of Pancreatic Cancer.
Biomed Res Int. 2020 Apr 28;2020:8604340. doi: 10.1155/2020/8604340. eCollection 2020.

本文引用的文献

2
Properties of the human Cdc45/Mcm2-7/GINS helicase complex and its action with DNA polymerase epsilon in rolling circle DNA synthesis.
Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):6042-7. doi: 10.1073/pnas.1203734109. Epub 2012 Apr 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验